Abstract
Neural networks and machine learning are two methods that are increasingly being used to model QSARs. They make few statistical assumptions and are nonlinear and nonparametric. We describe back-propagation from the field of neural networks, and GOLEM from machine learning, and illustrate their learning mechanisms using a simple expository problem. Back-propagation and GOLEM are then compared with multiple linear regression (using the parameters and their squares) on two real drug design problems: the inhibition of Escherichia coli dihydrofolate reductase (DHFR) by pyrimidines and the inhibition of rat/mouse tumour DHFR by triazines. © 1993 ESCOM Science Publishers B.V.
Original language | English |
---|---|
Pages (from-to) | 279-290 |
Number of pages | 11 |
Journal | Perspectives in Drug Discovery and Design |
Volume | 1 |
Issue number | 2 |
DOIs | |
Publication status | Published - Dec 1993 |
Keywords
- Artificial intelligence
- Drug design